Industry Developments

India's Plethico Pharmaceuticals is targeting acquisitions in the US and Brazil in order to expand its Americas over-the-counter (OTC) and nutraceuticals businesses, according to... 2008-06-20

Following the launch of its breakthrough rheumatoid arthritis therapeutic, US drugmaker Abbott Laboratories is looking to outperform the Japanese patented drug sector over the next... 2008-06-20

Boosting Australia's reputation for high quality biomedical R&D, the Therapeutic Goods Administration (TGA) has approved local firm CSL's avian influenza vaccine, Panvax. Launch... 2008-06-20

Despite the registration of a new medicine, the burden of Parkinson's disease in the US will continue to grow through to 2030. UK firm GlaxoSmithKline (GSK)'s Requip XL (extended-release... 2008-06-18

In an effort to diversify and increase its presence in emerging markets, Japanese drugmaker Daiichi Sankyo has purchased a controlling stake in Indian generics firm Ranbaxy Laboratories.... 2008-06-12

Bangladesh's status as an emerging contract manufacturing centre was underlined after Renata became the second local company to be allowed to export pharmaceuticals to a Western European... 2008-06-05

In order to increase its exposure in foreign markets, Bangladeshi drugmaker Square Pharmaceuticals has signed a distribution agreement with Sri Lankan firm PC Pharma. A challenging... 2008-06-04

Due to the significant burden of liver cancer in Asia, US firm Onyx Pharmaceuticals and German multinational Bayer plan to roll-out Nexavar (sorafenib) in the region using a 'stepwise'... 2008-06-04

In an effort to expand into South America and Western Europe, Indian healthcare provider Apollo Hospitals Group is evaluating acquisition targets in Peru and Spain. The group has... 2008-06-02

In order to further penetrate the largest pharmaceutical market in South East Asia, Malaysian firm Pharmaniaga is planning to purchase a medium-sized Indonesian drugmaker. The move... 2008-05-27